Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|June 24, 2022
Modified Fluoroquinolones as Antimicrobial Compounds Targeting Chlamydia trachomatisThi Huyen Vu, Erika Adhel, Katarina Vielfort, et al.
Frontiers in Microbiology|September 13, 2023
Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9Susie Gaillot, Saoussen Oueslati, Jean-Baptiste Vuillemenot, et al.
Applied and Environmental Microbiology|February 1, 2015
Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putidaSylvie Mazurier, Annabelle Merieau, Dorian Bergeau, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2014
New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharidesGuillaume Sautrey, Louis Zimmermann, Magali Deleu, et al.
Plos Pathogens|December 5, 2012
Unique biofilm signature, drug susceptibility and decreased virulence in Drosophila through the Pseudomonas aeruginosa two-component system PprABSophie de Bentzmann, Caroline Giraud, Christophe S Bernard, et al.
Plos One|January 28, 2014
Antibiotic resistance determinants in a Pseudomonas putida strain isolated from a hospitalLázaro Molina, Zulema Udaondo, Estrella Duque, et al.
Plos Pathogens|December 2, 2024
Serotype switching in Pseudomonas aeruginosa ST111 enhances adhesion and virulenceMikkel Anbo, Mahbuba Akter Lubna, Dina A Moustafa, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2007
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infectionsDidier Hocquet, Philippe Berthelot, Micheline Roussel-Delvallez, et al.
International Journal of Molecular Sciences|May 27, 2023
6-Polyaminosteroid Squalamine Analogues Display Antibacterial Activity against Resistant PathogensDelphine Vergoz, Flore Nilly, Florie Desriac, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2025
Contribution of mutational resistance mechanisms and acquired β-lactamases to cefiderocol/xeruborbactam susceptibility in Pseudomonas aeruginosaLucía González-Pinto, María Antonia Gomis-Font, Gloria Pérez-Rodríguez, et al.
Pageof 7